TrialWorld journal of gastroenterology2005

Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.

Wolfgang Kruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.